UNSPSC 51143210: Altinicline maleate

This classification denotes a nicotinic agonist with the molecular formula C12H14N2.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PCL7Q9Q62Q, chemically known as pyridine, 3-ethynyl-5-((2s)-1-methyl-2-pyrrolidinyl)-, (2z)-2-butenedioate(1:1) but more generally known as altinicline maleate, which bears US NIH Compound Identifier 6442277. Most nations, for tariff and trade purposes, schedule altinicline maleate under HS 29339990 and SITC 51577. As of Q4 2014, ALTINICLINE MALEATE remains US FDA's Preferred Term for this commodity.

Altinicline maleate bears US NLM identifiers UMLS ID C2983930 and NCI Concept Code C90896. SMILES: CN1CCC[C@H]1C2CC(CNC2)C#C.C(=C\C(=O)O)\C(=O)O.

UNSPSC 51143210 Altinicline maleate is a Commodity code nominally describing a specific pharmaceutical active ingredient, but the recent state and local opportunities tagged to it involve procurement of finished pharmaceutical products and drug-management systems rather than bulk chemical compounds. Seminole County, Florida's IFB60459723LAS solicited 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually for community health initiatives, with quarterly deliveries and a two-year initial term plus one-year renewal option. The Texas Health and Human Services Commission issued RFI HHS0017013 to gather vendor capabilities on direct-to-manufacturer prescription fulfillment and pharmacy benefit program management, seeking information on vendors' experience with direct contracting for self-insured employer and government health plans, negotiated net pricing models, and value-based or outcomes-based service agreements. The mismatch between the code's nominal scope and the actual work being solicited suggests that this Commodity code does not reliably capture state and local pharmaceutical purchasing activity as currently applied.

Activity comes from county health departments and state health and human services agencies, with Seminole County (Florida) and the Texas Health and Human Services Commission representing the two most recent issuers. Seminole County's IFB closed July 26, 2023, requiring electronic bid submission through the county e-Procurement Portal, drug-free workplace certification, E-Verify compliance, and proof of workers' compensation and commercial general liability insurance. The Texas RFI, posted April 3, 2026, with the same response deadline, operated as an exploratory information-gathering mechanism to inform future pharmacy benefit program design rather than a formal competitive solicitation with binding award terms. Geographic activity appears limited to Florida and Texas based on recent postings, though the exploratory nature of the Texas RFI suggests potential expansion into broader state pharmacy procurement.